Astor Q3 review: recovery takes shape - Nuways
Bildkälla: Stockfoto

Astor Q3 review: recovery takes shape - Nuways

Astor's Q3 showed a clear recovery from the weaker second quarter. Stronger deliveries, improved cost absorption and a pickup in order intake provide a firmer base for further growth, despite uneven progress across the portfolio.

Order intake regained momentum. Orders increased 23% yoy and 120% qoq to SEK 178m. Although intake still lagged deliveries, book-to-bill improved to 0.7x from 0.5x in Q2. October's SEK 33m Marstrom infrastructure award provides an encouraging start to Q4, with high quotation activity supporting the prospect of further contract wins.

Ammunity and NSG support growth, with Industry adding margin upside potential. Ammunity's expanded capacity offers substantial volume upside, with a Latvian strategic partnership and new European customers representing potential catalysts. NSG benefits from infrastructure protection demand, and Industry's defence ramp should lift utilisation and margins. Selective acquisitions provide an additional route to growth.

Action: D&A assumptions raised slightly following higher-than-expected charges in Q3, partly reflecting PPA amortisation.

Reiterate BUY, unchanged PT of SEK 27, based on a blend of DCF and peer group valuation
Börsvärldens nyhetsbrev